Growth factors in the treatment of wasting in kidney failure

被引:6
作者
Chen, Y
Fervenza, FC
Rabkin, R
机构
[1] VAPAHCS, Res Serv, Palo Alto, CA 94304 USA
[2] Peking Univ, Hosp 1, Beijing 100871, Peoples R China
[3] Mayo Clin, Rochester, MN USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
关键词
D O I
10.1053/jren.2001.23468
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Protein-energy malnutrition is relatively common in patients with advanced renal failure and is associated with an increase in morbidity and mortality. Accordingly, there is a need to develop more effective treatments to enhance the nutritional status of these patients. One such approach is the use of recombinant growth factors and anabolic steroids for malnourished patients refractory to standard nutritional therapy. In this article, we review the current state of our knowledge regarding the potential use of these agents in malnourished renal failure patients and conclude that although the studies performed to date are indeed encouraging, further and more extensive clinical trials are required to firmly establish their efficacy and safety profile and the indications for clinical use. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:62 / 66
页数:5
相关论文
共 27 条
[1]  
Alvestrand A, 1997, KIDNEY INT, V52, pS48
[2]   Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients [J].
Biolo, G ;
Iscra, F ;
Bosutti, A ;
Toigo, G ;
Ciocchi, B ;
Geatti, O ;
Gullo, A ;
Guarnieri, G .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (02) :E323-E332
[3]   Treatments for wasting in patients with the acquired immunodeficiency syndrome [J].
Corcoran, C ;
Grinspoon, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (22) :1740-1750
[4]   Growth hormone therapy in critically ill patients [J].
Demling, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) :837-839
[5]   Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients [J].
Fouque, D ;
Peng, SC ;
Shamir, E ;
Kopple, JD .
KIDNEY INTERNATIONAL, 2000, 57 (02) :646-654
[6]   Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients [J].
Garibotto, G ;
Barreca, A ;
Russo, R ;
Sofia, A ;
Araghi, P ;
Cesarone, A ;
Malaspina, M ;
Fiorini, F ;
Minuto, F ;
Tizianello, A .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (01) :97-105
[7]   Effect of growth hormone treatment on the adult height of children with chronic renal failure. [J].
Haffner, D ;
Schaefer, F ;
Nissel, R ;
Wühl, E ;
Tönshoff, B ;
Mehls, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :923-930
[8]  
Hansen TB, 2000, CLIN NEPHROL, V53, P99
[9]   Early experience with extended use of insulin-like growth factor-1 in advanced chronic renal failure [J].
Ike, JO ;
Fervenza, FC ;
Hoffman, AR ;
Yeh, I ;
Hintz, RL ;
Liu, F ;
Rabkin, R .
KIDNEY INTERNATIONAL, 1997, 51 (03) :840-849
[10]   INTERVENTIONS TO TREAT MALNUTRITION IN DIALYSIS PATIENTS - THE ROLE OF THE DOSE OF DIALYSIS, INTRADIALYTIC PARENTERAL-NUTRITION, AND GROWTH-HORMONE [J].
IKIZLER, TA ;
WINGARD, RL ;
HAKIM, RM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) :256-265